You’ve heard about hydroxychloroquine, but do you know about Remdesivir, Roivant, and Athersys? If you’re keeping an eye on a possible vaccine, do you know there are more than a dozen vaccine candidates that are either doing trials now or hoping to start soon? This tracker from healthcare news outlet STAT has you covered.
The tracker doesn’t include every possible drug and vaccine effort, but it does list some of the “most talked about” and sorts them to put the ones whose development is the furthest along at the top of the chart.
Spreading faster than the coronavirus outbreak itself is the wealth of information about it. Despite there being plenty available, our understanding of the virus and its spread has been changing more rapidly than we can manage regular updates for. This is best shown with Australia's own case count. While it's provided through the federal health department, it's not being updated as quickly as others so figures soon become outdated. If you want to know how many confirmed coronavirus cases there are in Australia, here are some of the best sources to check.
For drugs, the top entry is Remdesivir, which has begun phase 3 trials. It was previously tested on SARS, MERS, and Ebola, in the hopes that it could act as an all-purpose antiviral. Now it’s being tested on COVID-19 patients, although the phase 3 trials in China were both suspended due to a lack of eligible patients.
Vaccines are being worked on around the world in light of the global health crisis being caused by coronavirus. With the wealth of information out there, it can be hard to keep up with where everything's at. Luckily, there's now a site to tell you where they're all happening.
Among vaccines, the top entry is Moderna’s mRNA vaccine, which began its phase 1 trials in March. None of the vaccine candidates have yet begun phase 2 trials, meaning it will be a while before we even know if any of them work, much less get a worldwide supply manufactured and distributed. We may be years away from the first vaccine (the fastest vaccine ever developed took four years), but with this chart we can keep an eye on how that process is going.